Results 71 to 80 of about 475,313 (268)

Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)

Journal of Thrombosis and Haemostasis, 2020
The Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism (SELECT‐D) trial demonstrated reduction in recurrent venous thromboembolism (VTE) but increased bleeding with rivaroxaban compared with dalteparin for
A. Marshall, M. Levine, C. Hill, Danielle Hale, Jenny Thirlwall, V. Wilkie, K. French, Ajay Kakkar, A. Lokare, A. Maraveyas, O. Chapman, A. Arif, S. Petrou, M. Maredza, F. Hobbs, J. Dunn, A. Young   +16 more
semanticscholar   +1 more source

A Benchmark, Expand, and Calibration (BenchExCal) Trial Emulation Approach for Using Real‐World Evidence to Support Indication Expansions: Design and Process for a Planned Empirical Evaluation

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world evidence involving healthcare database studies is well established for making causal inferences in post‐market drug safety studies and methods, data, and research infrastructure for evaluating effectiveness have advanced in recent years. The rapidly expanding field of etiologic research using insurance claims and electronic health records ...
Shirley V. Wang, Massimiliano Russo, Robert J. Glynn, Marie C. Bradley, Jiwei He, John Concato, Sebastian Schneeweiss   +6 more
wiley   +1 more source

Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 130, Issue 3, Page 303-311, February 2023., 2023
Abstract Objective To retrospectively describe a large series of pregnancies in women with hereditary haemorrhagic telangiectasia followed in our reference centre, plus neonatal outcomes, to better understand the risks of complications and to improve their prevention.
Laura Delagrange, Olivier Dupuis, Anne‐Emmanuelle Fargeton, Lorraine Bernard, Evelyne Decullier, Sophie Dupuis‐Girod   +5 more
wiley   +1 more source

Deformation Mechanics of Self-expanding Venous Stents: Modelling and Experiments [PDF]

arXiv, 2021
Deformation properties of venous stents based on braided design, chevron design, Z design, and diamond design are compared using in vitro experiments coupled with analytical and finite element modelling. Their suitability for deployment in different clinical contexts is assessed based on their deformation characteristics. Self-expanding stainless steel
arxiv  

Venous Thromboembolism in Progress [PDF]

Mayo Clinic Proceedings, 2011
A 67-year-old man with a history of inferior infarction was admitted to our hospital because of a near-syncopal episode, sudden dyspnea, and right-sided pleuritic chest pain. On physical examination, the patient appeared in distress with a blood pressure of 79/58 mm Hg and a heart rate of 123 beats/min.
Nicola Mumoli, Stefano Giuntoli
openaire   +3 more sources

Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes

Drug Testing and Analysis, EarlyView.
In highly trained female athletes, haematological and inflammatory biomarkers were found to be independent of menstrual cycle phase, but oral contraceptive use increased transferrin, reticulocyte count and triglycerides and decreased interleukin‐6.
Katia Collomp, Caroline Teulier, Carole Castanier, Juliette Bonnigal, Alexandre Marchand, Corinne Buisson, Magnus Ericsson, Nathalie Crépin, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, Virgile Amiot, Agnès Olivier   +12 more
wiley   +1 more source

Bayesian statistical models to explore the use glucometer measurements of capillary blood sugar for OGTT Tests [PDF]

arXiv, 2023
A common test for the diagnosis of type 2 diabetes is the Oral Glucose Tolerance Test (OGTT). Recent developments in the study of OGTT tests have framed it as a Bayesian inverse problem. These data analysis advances promise great improvements in the descriptive power of OGTTs.
arxiv  

Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry

Japanese Journal of Clinical Oncology, 2020
Background The Cancer-VTE Registry evaluates the occurrence and management of venous thromboembolism in Japanese participants with major solid tumors. Using Registry data, we evaluated the frequency of concurrent venous thromboembolism in cancer patients
Y. Ohashi, M. Ikeda, H. Kunitoh, M. Sasako, T. Okusaka, H. Mukai, K. Fujiwara, Mashio Nakamura, M. Oba, T. Kimura, Kei Ibusuki, M. Sakon   +11 more
semanticscholar   +1 more source

Venous thromboembolism and infection

African Journal of Thoracic and Critical Care Medicine, 2021
Venous thromboembolism (VTE), manifesting as either deep venous thrombosis (DVT), pulmonary embolism (PE) or both, remains a major cause of cardiovascular morbidity and mortality ...
openaire   +4 more sources

Treatment of venous thromboembolism [PDF]

Journal of Thrombosis and Haemostasis, 2005
This review on the treatment of patients with venous thromboembolic disease consists of three sections. The first section describes the epidemiology, natural history and reasons for treatment of venous thromboembolism (VTE), as well as a short overview on the evaluation of the use of antithrombotic agents and the spectrum of treatment options.
M. Sohne, H. R. Büller, S. Middeldorp
openaire   +3 more sources